company background image
C1IC

Cigna BOVESPA:C1IC34 Stock Report

Last Price

US$328.69

Market Cap

US$417.1b

7D

5.1%

1Y

-6.3%

Updated

14 May, 2022

Data

Company Financials +
C1IC34 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health2/6
Dividends5/6

C1IC34 Stock Overview

Cigna Corporation provides insurance and related products and services in the United States.

Cigna Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cigna
Historical stock prices
Current Share PriceUS$328.69
52 Week HighUS$352.24
52 Week LowUS$240.98
Beta0.78
1 Month Change8.03%
3 Month Change10.11%
1 Year Change-6.31%
3 Year Changen/a
5 Year Changen/a
Change since IPO55.74%

Recent News & Updates

Shareholder Returns

C1IC34BR HealthcareBR Market
7D5.1%-3.5%1.6%
1Y-6.3%-51.1%-19.2%

Return vs Industry: C1IC34 exceeded the BR Healthcare industry which returned -52% over the past year.

Return vs Market: C1IC34 exceeded the BR Market which returned -19.7% over the past year.

Price Volatility

Is C1IC34's price volatile compared to industry and market?
C1IC34 volatility
C1IC34 Average Weekly Movement5.7%
Healthcare Industry Average Movement6.2%
Market Average Movement6.3%
10% most volatile stocks in BR Market9.7%
10% least volatile stocks in BR Market3.2%

Stable Share Price: C1IC34 is not significantly more volatile than the rest of BR stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: C1IC34's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
179272,963David Cordanihttps://www.cigna.com

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.

Cigna Fundamentals Summary

How do Cigna's earnings and revenue compare to its market cap?
C1IC34 fundamental statistics
Market CapUS$82.23b
Earnings (TTM)US$5.39b
Revenue (TTM)US$176.99b

15.3x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
C1IC34 income statement (TTM)
RevenueUS$176.99b
Cost of RevenueUS$153.96b
Gross ProfitUS$23.03b
Other ExpensesUS$17.65b
EarningsUS$5.39b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 04, 2022

Earnings per share (EPS)16.98
Gross Margin13.01%
Net Profit Margin3.04%
Debt/Equity Ratio71.7%

How did C1IC34 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

25%

Payout Ratio

Does C1IC34 pay a reliable dividends?

See C1IC34 dividend history and benchmarks
When do you need to buy C1IC34 by to receive an upcoming dividend?
Cigna dividend dates
Ex Dividend DateJun 07 2022
Dividend Pay DateJun 29 2022
Days until Ex dividend23 days
Days until Dividend pay date45 days

Does C1IC34 pay a reliable dividends?

See C1IC34 dividend history and benchmarks

Valuation

Is Cigna undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


29.8%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: C1IC34 (R$328.69) is trading below our estimate of fair value (R$469.53)

Significantly Below Fair Value: C1IC34 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: C1IC34 is poor value based on its PE Ratio (15.3x) compared to the BR Healthcare industry average (12.7x).

PE vs Market: C1IC34 is poor value based on its PE Ratio (15.3x) compared to the BR market (8.7x).


Price to Earnings Growth Ratio

PEG Ratio: C1IC34 is poor value based on its PEG Ratio (2.2x)


Price to Book Ratio

PB vs Industry: C1IC34 is good value based on its PB Ratio (1.8x) compared to the BR Healthcare industry average (2.2x).


Future Growth

How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


6.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: C1IC34's forecast earnings growth (6.9% per year) is below the savings rate (9.1%).

Earnings vs Market: C1IC34's earnings (6.9% per year) are forecast to grow faster than the BR market (4.5% per year).

High Growth Earnings: C1IC34's earnings are forecast to grow, but not significantly.

Revenue vs Market: C1IC34's revenue (5.2% per year) is forecast to grow slower than the BR market (6.2% per year).

High Growth Revenue: C1IC34's revenue (5.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: C1IC34's Return on Equity is forecast to be low in 3 years time (16.3%).


Past Performance

How has Cigna performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


27.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: C1IC34 has high quality earnings.

Growing Profit Margin: C1IC34's current net profit margins (3%) are lower than last year (5.2%).


Past Earnings Growth Analysis

Earnings Trend: C1IC34's earnings have grown significantly by 27.5% per year over the past 5 years.

Accelerating Growth: C1IC34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: C1IC34 had negative earnings growth (-36.2%) over the past year, making it difficult to compare to the Healthcare industry average (49.4%).


Return on Equity

High ROE: C1IC34's Return on Equity (11.8%) is considered low.


Financial Health

How is Cigna's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: C1IC34's short term assets ($35.4B) do not cover its short term liabilities ($43.7B).

Long Term Liabilities: C1IC34's short term assets ($35.4B) do not cover its long term liabilities ($62.8B).


Debt to Equity History and Analysis

Debt Level: C1IC34's net debt to equity ratio (60.6%) is considered high.

Reducing Debt: C1IC34's debt to equity ratio has increased from 33.2% to 71.7% over the past 5 years.

Debt Coverage: C1IC34's debt is well covered by operating cash flow (24.5%).

Interest Coverage: C1IC34's interest payments on its debt are well covered by EBIT (6.4x coverage).


Balance Sheet


Dividend

What is Cigna current dividend yield, its reliability and sustainability?

Dividend Score

5/6

Dividend Score 5/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


1.73%

Current Dividend Yield

Upcoming Dividend Payment

TodayMay 14 2022Ex Dividend DateJun 07 2022Dividend Pay DateJun 29 202222 days from Ex DividendBuy in the next 23 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: C1IC34's dividend (1.73%) is higher than the bottom 25% of dividend payers in the BR market (1.49%).

High Dividend: C1IC34's dividend (1.73%) is low compared to the top 25% of dividend payers in the BR market (6.73%).


Stability and Growth of Payments

Stable Dividend: C1IC34's dividends per share have been stable in the past 10 years.

Growing Dividend: C1IC34's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (25.3%), C1IC34's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (20.5%), C1IC34's dividend payments are well covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average management tenure


CEO

David Cordani (56 yo)

13.92yrs

Tenure

US$19,872,266

Compensation

Mr. David Michael Cordani serves as Chair of the Board at Cigna Corporation since January 01, 2022. He has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and Ju...


CEO Compensation Analysis

Compensation vs Market: David's total compensation ($USD19.87M) is above average for companies of similar size in the BR market ($USD6.48M).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: C1IC34's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

Experienced Board: C1IC34's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cigna Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Cigna Corporation
  • Ticker: C1IC34
  • Exchange: BOVESPA
  • Founded: 1792
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: US$82.234b
  • Listing Market Cap: US$417.058b
  • Shares outstanding: 317.27m
  • Website: https://www.cigna.com

Number of Employees


Location

  • Cigna Corporation
  • 900 Cottage Grove Road
  • Bloomfield
  • Connecticut
  • 6002
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/14 00:00
End of Day Share Price2022/05/13 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.